{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:06:04Z","timestamp":1785189964444,"version":"3.55.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00467-022-05835-4","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T12:04:07Z","timestamp":1670933047000},"page":"2915-2928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vaccines and nephrotic syndrome: efficacy and safety"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-5326","authenticated-orcid":false,"given":"Andrea","family":"Angeletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lugani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"La Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Verrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Caridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"5835_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1440-1754.1998.00232.x","volume":"34","author":"P McIntyre","year":"1998","unstructured":"McIntyre P, Craig JC (1998) Prevention of serious bacterial infection in children with nephrotic syndrome. J Paediatr Child Health 34:314\u2013317","journal-title":"J Paediatr Child Health"},{"key":"5835_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00467-001-0817-7","volume":"17","author":"MJ Kemper","year":"2002","unstructured":"Kemper MJ, Altrogge H, Ganschow R, M\u00fcller-Wiefel DE (2002) Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatr Nephrol 17:413\u2013417","journal-title":"Pediatr Nephrol"},{"key":"5835_CR3","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00467-015-3219-y","volume":"31","author":"S Banerjee","year":"2016","unstructured":"Banerjee S, Dissanayake PV, Abeyagunawardena AS (2016) Vaccinations in children on immunosuppressive medications for renal disease. Pediatr Nephrol 31:1437\u20131448","journal-title":"Pediatr Nephrol"},{"key":"5835_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1542\/peds.99.1.35","volume":"99","author":"M Broyer","year":"1997","unstructured":"Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C (1997) Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 99:35\u201339","journal-title":"Pediatrics"},{"key":"5835_CR5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0140-6736(69)92330-7","volume":"2","author":"SR Meadow","year":"1969","unstructured":"Meadow SR, Weller RO, Archibald RW (1969) Fatal systemic measles in a child receiving cyclophosphamide for nephrotic syndrome. Lancet 2:876\u2013878","journal-title":"Lancet"},{"key":"5835_CR6","first-page":"e14913","volume":"13","author":"V Thadchanamoorthy","year":"2021","unstructured":"Thadchanamoorthy V, Dayasiri K (2021) Review on pneumococcal infection in children. Cureus 13:e14913","journal-title":"Cureus"},{"key":"5835_CR7","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00467-013-2538-0","volume":"28","author":"M Mantan","year":"2013","unstructured":"Mantan M, Pandharikar N, Yadav S, Chakravarti A, Sethi GR (2013) Seroprotection for hepatitis B in children with nephrotic syndrome. Pediatr Nephrol 28:2125\u20132130","journal-title":"Pediatr Nephrol"},{"key":"5835_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF00878360","volume":"6","author":"A La Manna","year":"1992","unstructured":"La Manna A, Polito C, Foglia AC, Di Toro A, Cafaro MR, Del Gado R (1992) Reduced response to hepatitis B virus vaccination in boys with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 6:251\u2013253","journal-title":"Pediatr Nephrol"},{"key":"5835_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s13312-019-1589-0","volume":"56","author":"N Neupane","year":"2019","unstructured":"Neupane N, Krishnamurthy S, Jagadisan B, Dhodapkar R (2019) Hepatitis B seroprotection in pediatric nephrotic syndrome. Indian Pediatr 56:659\u2013662","journal-title":"Indian Pediatr"},{"key":"5835_CR10","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S1473-3099(20)30780-5","volume":"21","author":"T Vesikari","year":"2021","unstructured":"Vesikari T, Langley JM, Segall N, Ward BJ, Cooper C, Poliquin G, Smith B, Gantt S, McElhaney JE, Dionne M, van Damme P, Leroux-Roels I, Leroux-Roels G, Machluf N, Spaans JN, Yassin-Rajkumar B, Anderson DE, Popovic V, Diaz-Mitoma F, PROTECT Study Group (2021) Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial. Lancet Infect Dis 21:1271\u20131281","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"5835_CR11","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","volume":"20","author":"E Miller","year":"2001","unstructured":"Miller E, Salisbury D, Ramsay M (2001) Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20(Suppl 1):S58-67","journal-title":"Vaccine"},{"key":"5835_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1056\/NEJMoa1901229","volume":"382","author":"SN Ladhani","year":"2020","unstructured":"Ladhani SN, Andrews N, Parikh SR, Campbell H, White J, Edelstein M, Bai X, Lucidarme J, Borrow R, Ramsay ME (2020) Vaccination of infants with meningococcal group B vaccine (4CMenB) in England. N Engl J Med 382:309\u2013317","journal-title":"N Engl J Med"},{"key":"5835_CR13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/jnci\/djaa010","volume":"112","author":"SH Tsang","year":"2020","unstructured":"Tsang SH, Sampson JN, Schussler J, Porras C, Wagner S, Boland J, Cortes B, Lowy DR, Schiller JT, Schiffman M, Kemp TJ, Rodriguez AC, Quint W, Gail MH, Pinto LA, Gonzalez P, Hildesheim A, Kreimer AR, Herrero R, Costa Rica HPV Vaccine Trial (CVT) Group (2020) Durability of cross-protection by different schedules of the bivalent HPV vaccine: the CVT Trial. J Natl Cancer Inst 112:1030\u20131037","journal-title":"J Natl Cancer Inst"},{"key":"5835_CR14","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P\u00e9rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T\u00fcreci \u00d6, Nell H, Schaefer A, \u00dcnal S, Tresnan DB, Mather S, Dormitzer PR, \u015eahin U, Jansen KU, Gruber WC, C4591001 Clinical Trial Group (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603\u20132615","journal-title":"N Engl J Med"},{"key":"5835_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T, COVE Study Group (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384:403\u2013416","journal-title":"N Engl J Med"},{"key":"5835_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA, Weckx LY et al (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397:99\u2013111","journal-title":"Lancet"},{"key":"5835_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa2107456","volume":"385","author":"RW Frenck Jr","year":"2021","unstructured":"Frenck RW Jr, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, Perez JL, Walter EB, Senders S, Bailey R, Swanson KA, Ma H, Xu X, Koury K, Kalina WV, Cooper D, Jennings T, Brandon DM, Thomas SJ, T\u00fcreci \u00d6, Tresnan DB, Mather S, Dormitzer PR, \u015eahin U, Jansen KU, Gruber WC, C4591001 Clinical Trial Group (2021) Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med 385:239\u2013250","journal-title":"N Engl J Med"},{"key":"5835_CR18","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMoa2109522","volume":"385","author":"K Ali","year":"2021","unstructured":"Ali K, Berman G, Zhou H, Deng W, Faughnan V, Coronado-Voges M, Ding B, Dooley J, Girard B, Hillebrand W, Pajon R, Miller JM, Leav B, McPhee R (2021) Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. N Engl J Med 385:2241\u20132251","journal-title":"N Engl J Med"},{"key":"5835_CR19","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","volume":"396","author":"MN Ramasamy","year":"2021","unstructured":"Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL et al (2021) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial. Lancet 396:1979\u20131993","journal-title":"Lancet"},{"key":"5835_CR20","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, C\u00e1rdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, Offergeld K, Scheper G, Taylor KL, Robb ML, Treanor J, Barouch DH, Stoddard J, Ryser MF, Marovich MA, Neuzil KM, Corey L, Cauwenberghs N, Tanner T, Hardt K, Ruiz-Gui\u00f1az\u00fa J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M, ENSEMBLE Study Group (2021) Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med 384:2187\u20132201","journal-title":"N Engl J Med"},{"issue":"217\u2013222","key":"5835_CR21","first-page":"e1","volume":"196","author":"K Kamei","year":"2018","unstructured":"Kamei K, Miyairi I, Ishikura K, Ogura M, Shoji K, Funaki T, Ito R, Arai K, Abe J, Kawai T, Onodera M, Ito S (2018) Prospective study of live attenuated vaccines for patients with nephrotic syndrome receiving immunosuppressive agents. J Pediatr 196(217\u2013222):e1","journal-title":"J Pediatr"},{"key":"5835_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bmj.4.5841.665-a","volume":"4","author":"JA Kuzemko","year":"1972","unstructured":"Kuzemko JA (1972) Measles vaccination and the nephrotic syndrome. Br Med J 4:665\u2013666","journal-title":"Br Med J"},{"key":"5835_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s13312-021-2161-2","volume":"58","author":"M Ajay","year":"2021","unstructured":"Ajay M, Mantan M, Dabas A, Asraf A, Yadav S, Chakravarti A (2021) Seroprotection for Diphtheria, Pertussis, Tetanus and Measles in children with nephrotic syndrome. Indian Pediatr 58:233\u2013236","journal-title":"Indian Pediatr"},{"key":"5835_CR24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/bmj.299.6702.796-a","volume":"299","author":"AS Ahuja","year":"1989","unstructured":"Ahuja AS, Wright M (1989) MMR and the nephrotic syndrome. BMJ 299:796","journal-title":"BMJ"},{"key":"5835_CR25","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0022-3476(97)70094-5","volume":"131","author":"RM Quien","year":"1997","unstructured":"Quien RM, Kaiser BA, Deforest A, Polinsky MS, Fisher M, Baluarte HJ (1997) Response to the varicella vaccine in children with nephrotic syndrome. J Pediatr 131:688\u2013690","journal-title":"J Pediatr"},{"key":"5835_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00467-001-0789-7","volume":"17","author":"H Alpay","year":"2002","unstructured":"Alpay H, Yildiz N, Onar A, Temizer H, Oz\u00e7ay S (2002) Varicella vaccination in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 17:181\u2013183","journal-title":"Pediatr Nephrol"},{"key":"5835_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1067\/mpd.2003.37","volume":"142","author":"SL Furth","year":"2003","unstructured":"Furth SL, Arbus GS, Hogg R, Tarver J, Chan C, Fivush BA, Southwest Pediatric Nephrology Study Group (2003) Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group. J Pediatr 142:145\u2013148","journal-title":"J Pediatr"},{"key":"5835_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1542\/peds.69.2.219","volume":"69","author":"JS Spika","year":"1982","unstructured":"Spika JS, Halsey NA, Fish AJ, Lum GM, Lauer BA, Schiffman G, Giebink GS (1982) Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome. Pediatrics 69:219\u2013223","journal-title":"Pediatrics"},{"key":"5835_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000185210","volume":"50","author":"EH Garin","year":"1988","unstructured":"Garin EH, Barrett DJ (1988) Pneumococcal polysaccharide immunization in patients with active nephrotic syndrome. Nephron 50:383\u2013388","journal-title":"Nephron"},{"key":"5835_CR30","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/infdis\/137.6.818","volume":"137","author":"SM Fikrig","year":"1978","unstructured":"Fikrig SM, Schiffman G, Phillipp JC, Moel DI (1978) Antibody response to capsular polysaccharide vaccine of Streptococcus pneumoniae in patients with nephrotic syndrome. J Infect Dis 137:818\u2013821","journal-title":"J Infect Dis"},{"key":"5835_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0272-6386(82)80042-5","volume":"2","author":"JC Wilkes","year":"1982","unstructured":"Wilkes JC, Nelson JD, Worthen HG, Morris M, Hogg RJ (1982) Response to pneumococcal vaccination in children with nephrotic syndrome. Am J Kidney Dis 2:43\u201346","journal-title":"Am J Kidney Dis"},{"key":"5835_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000166769","volume":"4","author":"A Tejani","year":"1984","unstructured":"Tejani A, Fikrig S, Schiffman G, Gurumurthy K (1984) Persistence of protective pneumococcal antibody following vaccination in patients with the nephrotic syndrome. Am J Nephrol 4:32\u201337","journal-title":"Am J Nephrol"},{"key":"5835_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0272-6386(86)80186-X","volume":"7","author":"JS Spika","year":"1986","unstructured":"Spika JS, Halsey NA, Le CT, Fish AJ, Lum GM, Lauer BA, Schiffman G, Giebink GS (1986) Decline of vaccine-induced antipneumococcal antibody in children with nephrotic syndrome. Am J Kidney Dis 7:466\u2013470","journal-title":"Am J Kidney Dis"},{"key":"5835_CR34","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/0264-410X(95)00093-G","volume":"13","author":"HJ Lee","year":"1995","unstructured":"Lee HJ, Kang JH, Henrichsen J, Konradsen HB, Jang SH, Shin HY, Ahn HS, Choi Y, Hessel L, Nam SW (1995) Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine 13:1533\u20131538","journal-title":"Vaccine"},{"key":"5835_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00467-003-1331-x","volume":"19","author":"AG G\u00fcven","year":"2004","unstructured":"G\u00fcven AG, Akman S, Bahat E, Senyurt M, Y\u00fczbey S, Uguz A, Yegin O (2004) Rapid decline of anti-pneumococcal antibody levels in nephrotic children. Pediatr Nephrol 19:61\u201365","journal-title":"Pediatr Nephrol"},{"key":"5835_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00467-008-0782-5","volume":"23","author":"T Ulinski","year":"2008","unstructured":"Ulinski T, Leroy S, Dubrel M, Danon S, Bensman A (2008) High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone. Pediatr Nephrol 23:1107\u20131113","journal-title":"Pediatr Nephrol"},{"key":"5835_CR37","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00467-010-1492-3","volume":"25","author":"B Aoun","year":"2010","unstructured":"Aoun B, Wannous H, Az\u00e9ma C, Ulinski T (2010) Polysaccharide pneumococcal vaccination of nephrotic children at disease onset-long-term data. Pediatr Nephrol 25:1773\u20131774","journal-title":"Pediatr Nephrol"},{"key":"5835_CR38","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1016\/j.vaccine.2011.07.053","volume":"29","author":"CD Liakou","year":"2011","unstructured":"Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI (2011) Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine 29:6834\u20136837","journal-title":"Vaccine"},{"key":"5835_CR39","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1016\/j.vaccine.2016.08.049","volume":"34","author":"LF Pittet","year":"2016","unstructured":"Pittet LF, Posfay-Barbe KM, Chehade H, Rudin C, Wilhelm-Bals A, Rodriguez M, Siegrist CA, Parvex P (2016) Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine. Vaccine 34:4948\u20134954","journal-title":"Vaccine"},{"key":"5835_CR40","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.vaccine.2013.11.106","volume":"32","author":"CD Liakou","year":"2014","unstructured":"Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI (2014) Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine 32:1394\u20131397","journal-title":"Vaccine"},{"key":"5835_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fped.2019.00339","volume":"7","author":"ST Goonewardene","year":"2019","unstructured":"Goonewardene ST, Tang C, Tan LT, Chan KG, Lingham P, Lee LH, Goh BH, Pusparajah P (2019) Safety and efficacy of pneumococcal vaccination in pediatric nephrotic syndrome. Front Pediatr 7:339","journal-title":"Front Pediatr"},{"key":"5835_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.ajkd.2010.04.011","volume":"56","author":"P Fernandes","year":"2010","unstructured":"Fernandes P, Jorge S, Lopes JA (2010) Relapse of nephrotic syndrome following the use of 2009 pandemic influenza A (H1N1) vaccine. Am J Kidney Dis 56:185\u2013186","journal-title":"Am J Kidney Dis"},{"key":"5835_CR43","first-page":"246","volume":"54","author":"JT Kielstein","year":"2000","unstructured":"Kielstein JT, Term\u00fchlen L, Sohn J, Kliem v, (2000) Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination. Clin Nephrol 54:246\u2013248","journal-title":"Clin Nephrol"},{"key":"5835_CR44","first-page":"414","volume":"32","author":"S Guti\u00e9rrez","year":"2012","unstructured":"Guti\u00e9rrez S, Dotto B, Petiti JP, De Paul AL, Dionisio de Cabalier ME, Torres AI, Mukdsi JH (2012) Minimal change disease following influenza vaccination and acute renal failure: just a coincidence? Nefrologia 32:414\u2013415","journal-title":"Nefrologia"},{"key":"5835_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/0377-4929.97893","volume":"55","author":"A Kutlucan","year":"2012","unstructured":"Kutlucan A, Gonen I, Yildizhan E, Aydin Y, Sav T, Yildirim U (2012) Can influenza H1N1 vaccination lead to the membranous glomerulonephritis? Indian J Pathol Microbiol 55:239\u2013241","journal-title":"Indian J Pathol Microbiol"},{"key":"5835_CR46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3349\/ymj.2010.51.6.895","volume":"51","author":"CO Kim","year":"2010","unstructured":"Kim CO, Nam CM, Lee DC, Han SH, Lee JW (2010) Clinical predictors of novel influenza A (H1N1)infection in Korea. Yonsei Med J 51:895\u2013900","journal-title":"Yonsei Med J"},{"key":"5835_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2165\/00003495-200060010-00004","volume":"60","author":"LB Brydak","year":"2000","unstructured":"Brydak LB, Machala M (2000) Humoral immune response to influenza vaccination in patients from high risk groups. Drugs 60:35\u201353","journal-title":"Drugs"},{"key":"5835_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00467-003-1301-3","volume":"19","author":"HM Poyrazo\u011flu","year":"2004","unstructured":"Poyrazo\u011flu HM, D\u00fc\u015f\u00fcnsel R, G\u00fcnd\u00fcz Z, Patiro\u011flu T, K\u00f6kl\u00fc S (2004) Antibody response to influenza A vaccination in children with nephrotic syndrome. Pediatr Nephrol 19:57\u201360","journal-title":"Pediatr Nephrol"},{"key":"5835_CR49","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1016\/j.vaccine.2015.06.049","volume":"33","author":"S Tanaka","year":"2015","unstructured":"Tanaka S, Saikusa T, Katafuchi Y, Ushijima K, Ohtsu Y, Tsumura N, Ito Y (2015) Serologic response after vaccination against influenza (A\/H1N1)pdm09 in children with renal disease receiving oral immunosuppressive drugs. Vaccine 33:5000\u20135004","journal-title":"Vaccine"},{"key":"5835_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12882-019-1240-2","volume":"20","author":"R Klifa","year":"2019","unstructured":"Klifa R, Toubiana J, Michel A, Biebuyck N, Charbit M, Heidet L, Krid S, Krug P, Salomon R, Boyer O (2019) Influenza vaccination among children with idiopathic nephrotic syndrome: an investigation of practices. BMC Nephrol 20:65","journal-title":"BMC Nephrol"},{"key":"5835_CR51","doi-asserted-by":"publisher","first-page":"23305","DOI":"10.1038\/s41598-021-02644-x","volume":"11","author":"S Ishimori","year":"2021","unstructured":"Ishimori S, Ando T, Kikunaga K, Terano C, Sato M, Komaki F, Hamada R, Hamasaki Y, Araki Y, Gotoh Y, Nakanishi K, Nakazato H, Matsuyama T, Iijima K, Yoshikawa N, Ito S, Honda M, Ishikura K (2021) Influenza virus vaccination in pediatric nephrotic syndrome significantly reduces rate of relapse and influenza virus infection as assessed in a nationwide survey. Sci Rep 11:23305","journal-title":"Sci Rep"},{"key":"5835_CR52","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2215\/CJN.01890221","volume":"16","author":"A Angeletti","year":"2021","unstructured":"Angeletti A, Bruschi M, Bianchin S, Bonato I, Montobbio C, Verrina E, Lugani F, Cravedi P, Ghiggeri GM (2021) Vaccines and disease relapses in children with nephrotic syndrome. Clin J Am Soc Nephrol 16:937\u2013938","journal-title":"Clin J Am Soc Nephrol"},{"key":"5835_CR53","doi-asserted-by":"publisher","first-page":"e600","DOI":"10.1542\/peds.2010-3137","volume":"128","author":"MT Liao","year":"2011","unstructured":"Liao MT, Chang MH, Lin FG, Tsai IJ, Chang YW, Tsau YK (2011) Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy. Pediatrics 128:e600-604","journal-title":"Pediatrics"},{"key":"5835_CR54","first-page":"349","volume":"43","author":"F Mac\u00e1rio","year":"1995","unstructured":"Mac\u00e1rio F, Freitas L, Correia J, Campos M, Marques A (1995) Nephrotic syndrome after recombinant hepatitis B vaccine. Clin Nephrol 43:349","journal-title":"Clin Nephrol"},{"key":"5835_CR55","first-page":"89","volume":"14","author":"I I\u015flek","year":"2000","unstructured":"I\u015flek I, Cengiz K, Cakir M, K\u00fc\u00e7\u00fck\u00f6d\u00fck S (2000) Nephrotic syndrome following hepatitis B vaccination. Pediatr Nephrol 14:89\u201390","journal-title":"Pediatr Nephrol"},{"key":"5835_CR56","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/oxfordjournals.ndt.a027900","volume":"13","author":"S Ozdemir","year":"1998","unstructured":"Ozdemir S, Bakkaloglu A, Oran O (1998) Nephrotic syndrome associated with recombinant hepatitis B vaccination: a causal relationship or just a mere association? Nephrol Dial Transplant 13:1888\u20131889","journal-title":"Nephrol Dial Transplant"},{"key":"5835_CR57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/00006454-200202000-00020","volume":"21","author":"M Pennesi","year":"2002","unstructured":"Pennesi M, Torre G, Del Santo M, Sonzogni A (2002) Glomerulonephritis after recombinant hepatitis B vaccine. Pediatr Infect Dis J 21:172\u2013173","journal-title":"Pediatr Infect Dis J"},{"key":"5835_CR58","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.vaccine.2013.05.004","volume":"31","author":"N Y\u0131ld\u0131z","year":"2013","unstructured":"Y\u0131ld\u0131z N, Sever L, Kasap\u00e7opur \u00d6, \u00c7ullu F, Ar\u0131soy N, \u00c7al\u0131\u015fkan S (2013) Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine 31:3309\u20133312","journal-title":"Vaccine"},{"key":"5835_CR59","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(03)14072-X","volume":"362","author":"AS Abeyagunawardena","year":"2003","unstructured":"Abeyagunawardena AS, Goldblatt D, Andrews N, Trompeter RS (2003) Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet 362:449\u2013450","journal-title":"Lancet"},{"key":"5835_CR60","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1136\/adc.2006.105247","volume":"92","author":"B Taylor","year":"2007","unstructured":"Taylor B, Andrews N, Stowe J, Hamidi-Manesh L, Miller E (2007) No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Arch Dis Child 92:887\u2013889","journal-title":"Arch Dis Child"},{"key":"5835_CR61","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1016\/j.vaccine.2019.07.017","volume":"37","author":"G De Serres","year":"2019","unstructured":"De Serres G, Billard MN, Gari\u00e9py MC, Roy MC, Boucher FD, Gagn\u00e9 H, Belley S, Toth E, Landry M, Skowronski DM (2019) Nephrotic syndrome following four-component meningococcal B vaccination: epidemiologic investigation of a surveillance signal. Vaccine 37:4996\u20135002","journal-title":"Vaccine"},{"key":"5835_CR62","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1016\/j.vaccine.2020.05.055","volume":"38","author":"N Andrews","year":"2020","unstructured":"Andrews N, Stowe J, Miller E (2020) Nephrotic syndrome in infants and toddlers before and after introduction of the meningococcal B vaccine programme in England: An ecological study. Vaccine 38:4816\u20134819","journal-title":"Vaccine"},{"key":"5835_CR63","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S2352-4642(18)30103-2","volume":"2","author":"P Bryan","year":"2018","unstructured":"Bryan P, Seabroke S, Wong J, Donegan K, Webb E, Goldsmith C, Vipond C, Feavers I (2018) Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study. Lancet Child Adolesc Health 2:395\u2013403","journal-title":"Lancet Child Adolesc Health"},{"key":"5835_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2807\/1560-7917.ES.2018.23.17.17-00468","volume":"23","author":"D Mentzer","year":"2018","unstructured":"Mentzer D, Oberle D, Keller-Stanislawski B (2018) Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016. Euro Surveill 23:17\u201300468","journal-title":"Euro Surveill"},{"key":"5835_CR65","doi-asserted-by":"crossref","unstructured":"Humphreys BD, Vanguri VK, Henderson J, Antin JH (2006) Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient. Nat Clin Pract Nephrol 2:535\u2013539; quiz 540","DOI":"10.1038\/ncpneph0271"},{"key":"5835_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2369-10-21","volume":"10","author":"C Clajus","year":"2009","unstructured":"Clajus C, Spiegel J, Br\u00f6cker V, Chatzikyrkou C, Kielstein JT (2009) Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphteria-poliomyelitis-vaccination. BMC Nephrol 10:21","journal-title":"BMC Nephrol"},{"key":"5835_CR67","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00467-020-04597-1","volume":"35","author":"M Melgosa","year":"2020","unstructured":"Melgosa M, Madrid A, Alv\u00e1rez O, Lumbreras J, Nieto F, Parada E, Perez-Beltr\u00e1n V, Spanish Pediatric Nephrology Association (2020) SARS-CoV-2 infection in Spanish children with chronic kidney pathologies. Pediatr Nephrol 35:1521\u20131524","journal-title":"Pediatr Nephrol"},{"key":"5835_CR68","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00467-021-05330-2","volume":"37","author":"W Morello","year":"2022","unstructured":"Morello W, Vianello FA, Proverbio E, Peruzzi L, Pasini A, Montini G (2022) COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area. Pediatr Nephrol 37:757\u2013764","journal-title":"Pediatr Nephrol"},{"key":"5835_CR69","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.2215\/CJN.06400420","volume":"15","author":"A Angeletti","year":"2020","unstructured":"Angeletti A, Drovandi S, Sanguineri F, Santaniello M, Ferrando G, Forno R, Cipresso G, Caridi G, Riella LV, Cravedi P, Ghiggeri GM (2020) COVID-19 in children with nephrotic syndrome on anti-CD20 chronic immunosuppression. Clin J Am Soc Nephrol 15:1494\u20131495","journal-title":"Clin J Am Soc Nephrol"},{"key":"5835_CR70","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s40620-022-01319-8","volume":"35","author":"A Angeletti","year":"2022","unstructured":"Angeletti A, Bruschi M, Bigatti C, Palmeri S, Lugani F, Verrina E, Ghiggeri GM (2022) An update on COVID-19 in paediatric and young adults with nephrotic syndrome, receiving chronic immunosuppression during the Omicron pandemic. J Nephrol 35:1775\u20131776","journal-title":"J Nephrol"},{"key":"5835_CR71","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMc2031364","volume":"383","author":"B Choi","year":"2020","unstructured":"Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo HH, Boucau J, Bowman K, Adhikari UD, Winkler ML, Mueller AA, Hsu TY, Desjardins M, Baden LR, Chan BT, Walker BD, Lichterfeld M, Brigl M, Kwon DS, Kanjilal S, Richardson ET, Jonsson AH, Alter G, Barczak AK, Hanage WP, Yu XG, Gaiha GD, Seaman MS, Cernadas M, Li JZ (2020) Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med 383:2291\u20132293","journal-title":"N Engl J Med"},{"key":"5835_CR72","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.kint.2021.09.002","volume":"100","author":"NL Li","year":"2021","unstructured":"Li NL, Coates PT, Rovin BH (2021) COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation? Kidney Int 100:959\u2013965","journal-title":"Kidney Int"},{"key":"5835_CR73","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.ajkd.2021.06.004","volume":"78","author":"AS Bomback","year":"2021","unstructured":"Bomback AS, Kudose S, D\u2019Agati VD (2021) De novo and relapsing glomerular diseases after COVID-19 vaccination: What Do We Know So Far? Am J Kidney Dis 78:477\u2013480","journal-title":"Am J Kidney Dis"},{"key":"5835_CR74","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.kint.2021.05.006","volume":"100","author":"N Schwotzer","year":"2021","unstructured":"Schwotzer N, Kissling S, Fakhouri F (2021) Letter regarding \u201cMinimal change disease relapse following SARS-CoV-2 mRNA vaccine.\u201d Kidney Int 100:458\u2013459","journal-title":"Kidney Int"},{"key":"5835_CR75","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.kint.2021.04.035","volume":"100","author":"VD D'Agati","year":"2021","unstructured":"D\u2019Agati VD, Kudose S, Bomback AS, Adamidis A, Tartini A (2021) Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney Int 100:461\u2013463","journal-title":"Kidney Int"},{"key":"5835_CR76","first-page":"662","volume":"118","author":"H Dormann","year":"2021","unstructured":"Dormann H, Kn\u00fcppel-Ruppert A, Amann K, Erley C (2021) Nephrotic syndrome after vaccination against COVID-19: three new cases from Germany. Dtsch Arztebl Int 118:662\u2013663","journal-title":"Dtsch Arztebl Int"},{"key":"5835_CR77","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/j.ajkd.2021.03.010","volume":"78","author":"L Lebedev","year":"2021","unstructured":"Lebedev L, Sapojnikov M, Wechsler A, Varadi-Levi R, Zamir D, Tobar A, Levin-Iaina N, Fytlovich S, Yagil Y (2021) Minimal change disease following the Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis 78:142\u2013145","journal-title":"Am J Kidney Dis"},{"key":"5835_CR78","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1053\/j.ajkd.2021.05.003","volume":"78","author":"RJ Maas","year":"2021","unstructured":"Maas RJ, Gianotten S, van der Meijden WAG (2021) An additional case of minimal change disease following the Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis 78:312","journal-title":"Am J Kidney Dis"},{"key":"5835_CR79","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.kint.2021.06.004","volume":"100","author":"J Weijers","year":"2021","unstructured":"Weijers J, Alvarez C, Hermans MMH (2021) Post-vaccinal minimal change disease. Kidney Int 100:459\u2013461","journal-title":"Kidney Int"},{"key":"5835_CR80","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.kint.2021.04.033","volume":"100","author":"D Kervella","year":"2021","unstructured":"Kervella D, Jacquemont L, Chapelet-Debout A, Deltombe C, Ville S (2021) Minimal change disease relapse following SARS-CoV-2 mRNA vaccine. Kidney Int 100:457\u2013458","journal-title":"Kidney Int"},{"key":"5835_CR81","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/j.ajkd.2021.05.006","volume":"78","author":"H Komaba","year":"2021","unstructured":"Komaba H, Wada T, Fukagawa M (2021) Relapse of minimal change disease following the Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis 78:469\u2013470","journal-title":"Am J Kidney Dis"},{"key":"5835_CR82","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.ekir.2021.07.017","volume":"6","author":"F Salem","year":"2021","unstructured":"Salem F, Rein JL, Yu SM, Abramson M, Cravedi P, Chung M (2021) Report of three cases of minimal change disease following the second dose of mRNA SARS-CoV-2 COVID-19 vaccine. Kidney Int Rep 6:2523\u20132524","journal-title":"Kidney Int Rep"},{"key":"5835_CR83","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.kint.2021.05.007","volume":"100","author":"A Holzworth","year":"2021","unstructured":"Holzworth A, Couchot P, Cruz-Knight W, Brucculeri M (2021) Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine. Kidney Int 100:463\u2013464","journal-title":"Kidney Int"},{"key":"5835_CR84","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12882-021-02583-9","volume":"22","author":"S Thappy","year":"2021","unstructured":"Thappy S, Thalappil SR, Abbarh S, Al-Mashdali A, Akhtar M, Alkadi MM (2021) Minimal change disease following the Moderna COVID-19 vaccine: first case report. BMC Nephrol 22:376","journal-title":"BMC Nephrol"},{"key":"5835_CR85","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1093\/ckj\/sfab156","volume":"14","author":"S Kobayashi","year":"2021","unstructured":"Kobayashi S, Fugo K, Yamazaki K, Terawaki H (2021) Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination. Clin Kidney J 14:2606\u20132607","journal-title":"Clin Kidney J"},{"key":"5835_CR86","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s40620-021-01091-1","volume":"34","author":"N Mancianti","year":"2021","unstructured":"Mancianti N, Guarnieri A, Tripodi S, Salvo DP, Garosi G (2021) Minimal change disease following vaccination for SARS-CoV-2. J Nephrol 34:1039\u20131040","journal-title":"J Nephrol"},{"key":"5835_CR87","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13730-021-00656-0","volume":"11","author":"E Nakazawa","year":"2022","unstructured":"Nakazawa E, Uchimura T, Hirai Y, Togashi H, Oyama Y, Inaba A, Shiga K, Ito S (2022) New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review. CEN Case Rep 11:242\u2013246","journal-title":"CEN Case Rep"},{"key":"5835_CR88","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1093\/ckj\/sfac134","volume":"15","author":"A Hummel","year":"2022","unstructured":"Hummel A, Oniszczuk J, Kervella D, Charbit M, Guerrot D, Testa A, Philipponnet C, Chauvet C, Guincestre T, Brochard K, Benezech A, Figueres L, Belenfant X, Guarnieri A, Demoulin N, Benetti E, Miglinas M, Dessaix K, Morelle J, Angeletti A, Sellier-Leclerc AL, Ranchin B, Goussard G, Hudier L, Bacchetta J, Servais A, Audard V (2022) Idiopathic nephrotic syndrome relapse following SARS-CoV-2 vaccination: a series of 25 cases. Clin Kidney J 15:1574\u20131582","journal-title":"Clin Kidney J"},{"key":"5835_CR89","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10157-022-02231-y","volume":"26","author":"N Nakagawa","year":"2022","unstructured":"Nakagawa N, Maruyama S, Kashihara N, Narita I, Isaka Y (2022) New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan. Clin Exp Nephrol 26:909\u2013916","journal-title":"Clin Exp Nephrol"},{"key":"5835_CR90","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/j.ajkd.2021.06.008","volume":"78","author":"S Leclerc","year":"2021","unstructured":"Leclerc S, Royal V, Lamarche C, Laurin LP (2021) Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 Vaccine: a case report. Am J Kidney Dis 78:607\u2013610","journal-title":"Am J Kidney Dis"},{"key":"5835_CR91","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.kint.2021.06.005","volume":"100","author":"C Morlidge","year":"2021","unstructured":"Morlidge C, El-Kateb S, Jeevaratnam P, Thompson B (2021) Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine. Kidney Int 100:459","journal-title":"Kidney Int"},{"key":"5835_CR92","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1093\/ckj\/sfab155","volume":"14","author":"S Unver","year":"2021","unstructured":"Unver S, Haholu A, Yildirim S (2021) Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine. Clin Kidney J 14:2608\u20132611","journal-title":"Clin Kidney J"},{"key":"5835_CR93","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/ckj\/sfab153","volume":"15","author":"VG Biradar","year":"2022","unstructured":"Biradar VG, Alqahtani MA, Nagaraj HC, Ahmed EA, Tripathi V, Botto-Tobar M, Atiglah HK (2022) Adult-onset nephrotic syndrome following coronavirus disease vaccination. Clin Kidney J 15:168\u2013170","journal-title":"Clin Kidney J"},{"key":"5835_CR94","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/ki.2012.280","volume":"82","author":"J Radhakrishnan","year":"2012","unstructured":"Radhakrishnan J, Cattran DC (2012) The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2014application to the individual patient. Kidney Int 82:840\u2013856","journal-title":"Kidney Int"},{"key":"5835_CR95","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1542\/peds.2008-1559","volume":"124","author":"DS Gipson","year":"2009","unstructured":"Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747\u2013757","journal-title":"Pediatrics"},{"issue":"11","key":"5835_CR96","first-page":"1","volume":"59","author":"JP Nuorti","year":"2010","unstructured":"Nuorti JP, Whitney CG, Centers for Disease Control and Prevention (CDC) (2010) Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59(11):1\u201318","journal-title":"MMWR Recomm Rep"},{"key":"5835_CR97","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00467-015-3241-0","volume":"31","author":"J McCaffrey","year":"2016","unstructured":"McCaffrey J, Lennon R, Webb NJ (2016) The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol 31:1383\u20131402","journal-title":"Pediatr Nephrol"},{"key":"5835_CR98","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","volume":"35","author":"A Trautmann","year":"2020","unstructured":"Trautmann A, Vivarelli M, Samuel S, Gipson D, Sinha A, Schaefer F, Hui NK, Boyer O, Saleem MA, Feltran L, M\u00fcller-Deile J, Becker JU, Cano F, Xu H, Lim YN, Smoyer W, Anochie I, Nakanishi K, Hodson E, Haffner D, International Pediatric Nephrology Association (2020) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 35:1529\u20131561","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05835-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05835-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05835-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:39:11Z","timestamp":1744209551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05835-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":98,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5835"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05835-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}